Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
New Drug Regimen Extends Survival for Cervical Cancer Patients
In some good news for women battling locally advanced cervical cancer, new research shows that adding six weeks of chemotherapy to standard treatment cuts the r
Tenecteplase Has Similar Safety to TPA for Acute Ischemic Stroke
For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and similar safety to alteplase (tissue
Excess Adiposity Plays Role in Postmenopausal HR-Positive Breast Cancer
Excess body fat plays a role in postmenopausal hormone receptor-positive breast cancer, which could be underestimated using only body mass index (BMI), accordin
Kidney Transplant Noninferior From Donors With Versus Without HIV in HIV-Positive Recipients
Among recipients with HIV, kidney transplantation from donors with HIV is noninferior to that from donors without HIV, according to a study published online Oct
Stereotactic Body Radiotherapy Viable Alternative for Localized Prostate Cancer
Stereotactic body radiotherapy (SBRT) is noninferior to conventional or moderately fractionated radiotherapy for localized prostate cancer (PC), according to a
2013 to 2021 Saw Decline in Benzodiazepine Initiation Post-AIS
From 2013 to 2021, there was a decline in benzodiazepine initiation for post-acute ischemic stroke (AIS), according to a study published online Oct. 17 in Strok
Vaping Rates Hit Record Lows for U.S. High School Students
Is vaping finally losing its coolness for American teens The latest tally of federal data finds that 550,000 school kids, mostly high schoolers, quit using e-ci
Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
Novavax, Inc. (Nasdaq NVAX), a global company advancing protein-based vaccines with its Matrix-M adjuvant, today announced that the U.S. Food and Drug Administr
Kidney Transplants Safe When Donor, Recipient Both HIV-Positive
21 and 24 , respectively, after three years, the researchers reported. Other surgical complications, including side effects, also showed few differences.The onl
New Combo Drug Therapy Halves Death Risk From Advanced Hodgkin Lymphoma
those aged 60 and above.According to Friedberg, who spoke in the University of Rochester interview, progress against Hodgkin lymphoma has been one of cancer res
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions